Ligand validation:2BHW

XAT: (3S,5R,6S,3'S,5'R,6'S)-5,6,5',6'-DIEPOXY-5,6,5',6'- TETRAHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL

XAT is a Ligand Of Interest in 2BHW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2BHW_XAT_A_504	45%	6%	0.18	0.91	2.21	2.85	15	20	15	2	100%	1
2BHW_XAT_C_504	31%	7%	0.203	0.872	2.2	2.64	13	21	13	2	100%	1
2BHW_XAT_B_504	31%	6%	0.214	0.882	2.2	2.85	14	21	14	2	100%	1
1RWT_XAT_J_3622	61%	50%	0.141	0.93	0.72	1.21	1	4	1	0	100%	1
7DKZ_XAT_4_317	70%	0%	0.148	0.965	5.05	5.3	17	32	10	3	100%	1
5L8R_XAT_4_303	67%	24%	0.124	0.931	0.64	2.45	-	13	9	2	100%	1
4XK8_XAT_4_617	46%	18%	0.189	0.925	0.88	2.59	-	18	0	0	100%	1
6ZXS_XAT_4_304	25%	33%	0.263	0.901	0.69	1.92	1	12	4	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.